Stryker's OP-I implant nears Australian approval:
This article was originally published in Clinica
The Australian Drug Evaluation Committee has recommended that Stryker's OP-1 Implant be approved for the treatment of non-union long bone fractures secondary to trauma. The implant, licensed from Curis, has already received a similar recommendation in Europe, although the US FDA recently declined to grant approval. A final decision by the Australian Therapeutic Goods Agency is expected within three months.
You may also be interested in...
The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.
Virtual notified body audits of medtech manufacturers are already taking place through necessity. Now there is guidance concerning if, when, where and how these audits should be carried out.